Literature DB >> 21146691

Clinical characteristics and predictors of in-hospital mortality in acute heart failure with preserved left ventricular ejection fraction.

John T Parissis1, Ignatios Ikonomidis, Pinelopi Rafouli-Stergiou, Alexandre Mebazaa, Juan Delgado, Dimitrios Farmakis, Fabio Vilas-Boas, Ioannis Paraskevaidis, Maria Anastasiou-Nana, Ferenc Follath.   

Abstract

Acute heart failure (AHF) with preserved left ventricular ejection fraction (PLVEF) represents a significant part of AHF syndromes featuring particular characteristics. We sought to determine the clinical profile and predictors of in-hospital mortality in patients with AHF and PLVEF in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF). This survey is an international observational study of 4,953 patients admitted for AHF in 9 countries (6 European countries, Mexico, and Australia) from October 2006 to March 2007. Patients with PLVEF were defined by an LVEF ≥ 45%. Of the total cohort, 25% of patients had PLVEF. In-hospital mortality was significantly lower in this subgroup (7% vs 11% in patients with decreased LVEF, p = 0.013). Candidate variables included demographics, baseline clinical findings, and treatment. Multivariate logistic regression analysis showed that the variables independently associated with in-hospital mortality included systolic blood pressure at admission (p <0.001), serum sodium (p = 0.041), positive troponin result (p = 0.023), serum creatinine >2 mg/dl (p = 0.042), history of peripheral vascular disease and anemia (p = 0.004 and p = 0.015, respectively), secondary (hospitalization for other reason) versus primary AHF diagnosis (p = 0.043), and previous treatment with diuretics (p = 0.023) and angiotensin-converting enzyme inhibitors (p = 0.021). In conclusion, patients with AHF and PLVEF have lower in-hospital mortality than those with decreased LVEF. Low systolic blood pressure, low serum sodium, renal dysfunction, positive markers of myocardial injury, presence of co-morbidities such as peripheral vascular disease and anemia, secondary versus primary AHF diagnosis, and absence of treatment with diuretics and angiotensin-converting enzyme inhibitors at admission may identify high-risk patients with AHF and PLVEF.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21146691     DOI: 10.1016/j.amjcard.2010.08.044

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

Review 1.  Deep Phenotyping of Systemic Arterial Hemodynamics in HFpEF (Part 2): Clinical and Therapeutic Considerations.

Authors:  Julio A Chirinos
Journal:  J Cardiovasc Transl Res       Date:  2017-04-11       Impact factor: 4.132

2.  Role of Cardiac Troponin Levels in Acute Heart Failure.

Authors:  Nicholas Wettersten; Alan Maisel
Journal:  Card Fail Rev       Date:  2015-10

3.  Biomarker predictors of cardiac hospitalization in chronic heart failure: a recurrent event analysis.

Authors:  Esther Vorovich; Benjamin French; Bonnie Ky; Lee Goldberg; James C Fang; Nancy K Sweitzer; Thomas P Cappola
Journal:  J Card Fail       Date:  2014-06-11       Impact factor: 5.712

4.  Differences in clinical characteristics, management and short-term outcome between acute heart failure patients chronic obstructive pulmonary disease and those without this co-morbidity.

Authors:  John T Parissis; Chiara Andreoli; Nikolaos Kadoglou; Ignatios Ikonomidis; Dimitrios Farmakis; Ioanna Dimopoulou; Efstathios Iliodromitis; Maria Anastasiou-Nana; Mitja Lainscak; Giussepe Ambrosio; Alexandre Mebazaa; Gerasimos Filippatos; Ferenc Follath
Journal:  Clin Res Cardiol       Date:  2014-04-10       Impact factor: 5.460

5.  Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.

Authors:  Dimitrios Farmakis; Panagiotis Simitsis; Vasiliki Bistola; Filippos Triposkiadis; Ignatios Ikonomidis; Spyridon Katsanos; George Bakosis; Erifili Hatziagelaki; John Lekakis; Alexandre Mebazaa; John Parissis
Journal:  Clin Res Cardiol       Date:  2016-12-20       Impact factor: 5.460

Review 6.  Clinical relevance of biomarkers in heart failure and cardiorenal syndrome: the role of natriuretic peptides and troponin.

Authors:  Alberto Palazzuoli; Serge Masson; Claudio Ronco; Alan Maisel
Journal:  Heart Fail Rev       Date:  2014-03       Impact factor: 4.214

7.  N-terminal pro b-type natriuretic peptide (NT-pro-BNP) -based score can predict in-hospital mortality in patients with heart failure.

Authors:  Ya-Ting Huang; Yuan-Teng Tseng; Tung-Wei Chu; John Chen; Min-Yu Lai; Woung-Ru Tang; Chih-Chung Shiao
Journal:  Sci Rep       Date:  2016-07-14       Impact factor: 4.379

8.  Elevation in systolic blood pressure during heart failure hospitalization is associated with increased short and long-term mortality.

Authors:  Omer Segal; Gad Segal; Avshalom Leibowitz; Ilan Goldenberg; Ehud Grossman; Robert Klempfner
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

9.  Prognostic significance of heart rate turbulence parameters in patients with chronic heart failure.

Authors:  De-Chun Yin; Zhao-Jun Wang; Shuai Guo; Hong-Yu Xie; Lin Sun; Wei Feng; Wei Qiu; Xiu-Fen Qu
Journal:  BMC Cardiovasc Disord       Date:  2014-04-13       Impact factor: 2.298

10.  Outcomes of patients with anemia and renal dysfunction in hospitalized heart failure with preserved ejection fraction (from the CN-HF registry).

Authors:  Xuejuan Jin; Juan Cao; Jun Zhou; Yanyan Wang; Xueting Han; Yu Song; Yuyuan Fan; Zhenyue Chen; Dingli Xu; Xinchun Yang; Wei Dong; Liwen Li; Li Chen; Qiaoqing Zhong; Micheal Fu; Kai Hu; Jingmin Zhou; Junbo Ge
Journal:  Int J Cardiol Heart Vasc       Date:  2019-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.